Pacific Biosciences of California, Inc.
A biotech company that builds machines for reading the long stretches of DNA that make up genes, known as PacBio. Its sequencers use a technology that "eavesdrops" on a single enzyme as it copies DNA, watching each letter being added in real time — used in medical research, agriculture, and microbiology. It was founded in 2004 as Nanofluidics, Inc., renamed Pacific Biosciences of California in 2005 after its home on the Pacific Coast, and launched its first commercial sequencer, the PacBio RS, in 2010.
Granted 920.8K · Sold 485.2K
Granted 500.0K · Sold 191.4K
Granted 333.8K · Sold 88.2K
Granted 89.8K · Sold 53.1K
Granted 111.4K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Henry Christian OSee Remarks · 4 transactions | +13.8% | 3.58M | 920.8K | — | 485.2K |
| Van Oene MarkSee Remarks · 4 transactions | +16.9% | 2.24M | 500.0K | — | 191.4K |
| Gibson James R IISee Remarks · 2 transactions | +24.6% | 1.25M | 333.8K | — | 88.2K |
| Farmer MicheleSee Remarks · 4 transactions | +13.6% | 305.9K | 89.8K | — | 53.1K |
| Gibson ChristopherDirector · 2 transactions | — | 111.4K | 111.4K | — | — |
Select a row to see that insider’s individual transactions.
Net open-market activity over the last year: -817.9K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.